By Chris Hutching
Friday 27th October 2000
|Text too small?|
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
C G Surgical was developed by engineer Richard Cathro. It has patents over a titanium and teflon clip which prevents pressure on the spinal cord. Pressure can cause neurological-related complaints.
No comments yet
Plexure's annualised revenue rises to $7.1M, mulls capital raise
RBNZ to pay $140 million dividend from FX gains in greener years
Wellington Airport wants to re-start resource consent for runway extension
Tertiary education system set up to preserve status quo: Productivity Commission
Z Energy more than halfway through service station divestments
CBL to raise up to $63 mln to accelerate expansion plans
NZ dollar little changed as Fed officials fail to give new direction
While you were sleeping: Oil climbs on OPEC deal
MARKET CLOSE: NZ shares gain, led by Chorus, Orion Health, Air NZ while Tower drops again
Consensus firms on need for bigger environmental regime overhaul